Director, US Market Access - Ecosystem Strategy & Market Development
Gilead Sciences
Summary
The Director, Ecosystem Strategy & Market Development reports to the Sr Director, Head of US Payer, Value, and Access Strategy and is a portfolio-level individual contributor responsible for developing and advancing long-range strategies that shape the external environment for CAR T and future cell therapies. This role will focus on improving ecosystem readiness, reducing structural barriers to patient access, and ensuring Kite has a clear Market Access point of view across employers, FACT, advocacy, public affairs, government affairs, policy, accreditation, and other external stakeholders critical to the future of cell therapy access.
Job description
Key Responsibilities
Ecosystem Strategy and Market Development
- Develop and execute a long-range ecosystem strategy and tactics to improve patient access to CAR T and future cell therapies
- Identify structural barriers that limit appropriate patient access, including referral friction, treatment center capacity, geographic access, provider readiness, reimbursement constraints, benefit design challenges, and policy barriers
- Translate complex external market dynamics into clear strategic priorities, initiatives, tactics, and recommendations for US Market Access leadership
- Develop market development strategies that support broader ecosystem readiness for future cell therapy growth, new treatment settings, and evolving care delivery models
- Serve as a strategic advisor to US Market Access and cross-functional partners on long-range access risks and market shaping opportunities
Employer Engagement Strategy
- Lead development of Kite's US employer engagement strategy in partnership with Payer & Value Marketing, Field Market Access, Government Affairs, Public Affairs, Legal, Compliance, and other relevant teams
- Develop employer stakeholder strategy, segmentation, educational priorities, and related tactics to improve understanding of CAR T value, benefit design considerations, and access barriers
- Partner with internal teams to develop employer-facing or employer-relevant resources, playbooks, and engagement approaches as appropriate
- Evaluate and pursue opportunities to engage employer coalitions, benefits consultants, large self-insured employers, stop-loss stakeholders, and other benefit decision-makers
- Ensure employer strategy and tactics are coordinated with payer strategy, value strategy, policy priorities, and broader market development objectives
FACT and Treatment Ecosystem Strategy
- Lead Kite's US Market Access strategy related to FACT and treatment ecosystem readiness
- Partner with internal stakeholders to ensure organizational alignment on FACT-related priorities, external engagement, implications for treatment center growth, and access considerations
- Monitor accreditation-related trends, treatment center requirements, capacity considerations, and standards that may influence future access to CAR T and cell therapy
- Coordinate with Provider Access Marketing, Field Market Access, Medical Affairs, Quality, GACO, Customer Engagement, and other partners to ensure FACT-related strategies are aligned with broader treatment center and provider access priorities
- Develop internal recommendations on how external standards, accreditation, and treatment ecosystem dynamics may support or constrain future patient access
Advocacy, Public Affairs, and Patient Access Stakeholder Strategy
- Lead US Market Access advocacy strategy in partnership with internal Advocacy, Public Affairs, Patient Services, Medical Affairs, Legal, Compliance, and other stakeholders
- Identify opportunities to partner with advocacy organizations, patient groups, professional societies, provider associations, and coalitions to address barriers to appropriate CAR T access
- Ensure Market Access perspectives are incorporated into advocacy strategy, external stakeholder engagement, patient access initiatives, and public affairs planning
- Partner with internal and external stakeholders to develop compliant, non-promotional initiatives that improve stakeholder understanding of access barriers and opportunities
- Serve as the US Market Access point of coordination for advocacy-related market development initiatives
Government Affairs and Policy Partnership
- Serve as the primary US Market Access partner to Government Affairs on policy issues that may impact CAR T and cell therapy access
- Identify policy barriers, reimbursement challenges, benefit design issues, and market access considerations that should inform government affairs priorities
- Partner with Government Affairs and Public Affairs to develop Market Access input into policy priorities, external engagement, coalition work, and market shaping efforts
- Support development of internal analyses, policy impact assessments, access implications, and strategic recommendations related to government and reimbursement policy
- Ensure policy-related work is clearly coordinated with Legal, Compliance, Government Affairs, and Public Affairs to maintain appropriate roles, governance, and external engagement standards
External Stakeholder and Coalition Strategy
- Identify, evaluate, and support strategic engagement with external stakeholders that can help improve CAR T access and ecosystem readiness
- Partner with cross-functional teams to engage employer coalitions, advocacy organizations, professional societies, accreditation bodies, provider associations, policy organizations, and other relevant groups
- Develop clear objectives, engagement plans, and measures of success for external market development initiatives
- Represent US Market Access in internal forums related to external partnerships, coalitions, and market shaping priorities
- Ensure Kite shows up as a credible, constructive, and solution-oriented partner in external discussions related to cell therapy access
Insights, Measurement, and Executive Communication
- Partner with CIAO, analytics, Field Market Access, HEOR, and other teams to identify insights related to market development priorities and ecosystem barriers
- Establish KPIs, milestones, and governance routines for ecosystem strategy and market development initiatives
- Provide regular updates to US Market Access Leadership on employer strategy, FACT strategy, advocacy alignment, policy priorities, and market shaping progress
- Develop executive-ready materials that translate complex external environment issues into clear business implications and recommendations
- Track external trends and anticipate future access risks related to policy, reimbursement, benefit design, accreditation, provider readiness, and care delivery evolution
Requirements
- Advanced scientific degree, such as MD, PharmD, or PhD, and 8+ years of experience OR Master's Degree and 10+ years of experience OR Bachelor's Degree and 12+ years of experience
- 10+ years of relevant pharmaceutical or biotechnology experience in market access, policy, advocacy, employer strategy, reimbursement, provider strategy, external affairs, public affairs, government affairs, HEOR, or related commercial roles
- Demonstrated experience developing strategies that influence external healthcare systems, stakeholder engagement, access policy, reimbursement, benefit design, or market development
- Strong understanding of CAR T, cell therapy, specialty therapy access, payer and provider economics, reimbursement, employer-sponsored coverage, and patient access barriers
- Experience working with or alongside Government Affairs, Public Affairs, Advocacy, Legal, Compliance, Medical Affairs, and Market Access teams
- Understanding of FACT, accreditation, treatment center dynamics, and provider ecosystem considerations preferred
- Experience with employer coalitions, benefits consultants, self-insured employers, stop-loss stakeholders, advocacy organizations, policy groups, or professional societies preferred
- Demonstrated ability to operate through influence in complex, ambiguous, matrixed environments
- Strong strategic thinking and analytical skills with ability to translate external market complexity into clear priorities and actionable recommendations
- Strong executive presence and ability to represent Market Access perspectives with senior internal and external stakeholders
- Demonstrated high levels of emotional intelligence, situational awareness, and enterprise partnership
- Excellent project management skills with ability to lead complex initiatives across multiple stakeholders and timelines
- Advanced PowerPoint and Excel skills
- Excellent verbal and written communication skills
Benefits
- Medical, Dental & Vision
- Life Insurance
- Discretionary Annual Bonus
- Stock-Based Long-Term Incentives
- Paid Time Off
Company overview
Gilead Sciences, Inc. is a leading American biopharmaceutical company headquartered in Foster City, California, that specializes in researching, developing, and commercializing innovative medicines for life-threatening diseases. Founded in 1987, Gilead has grown into a global healthcare leader with approximately 17,600 employees worldwide. The company's primary therapeutic focus areas include HIV/AIDS, viral hepatitis (hepatitis B and C), oncology, inflammation, and respiratory diseases. Gilead is renowned for its groundbreaking antiviral therapies, including Sovaldi and Harvoni for hepatitis C, and its comprehensive portfolio of HIV treatments such as Truvada, Atripla, and Biktarvy. The company also developed Veklury (remdesivir) for COVID-19 treatment. Gilead operates as a publicly traded company on the NASDAQ (GILD) and is a component of both the Nasdaq-100 and S&P 100 indices. Through strategic acquisitions like Kite Pharma and Immunomedics, Gilead has expanded into cell therapy and oncology, demonstrating its commitment to advancing medical science and improving patient outcomes globally.